US Patent Issued to Regeneron Pharmaceuticals on July 7 for "Mice expressing humanized Fc Alpha receptors" (New York Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,672,644, issued on July 7, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Mice expressing humanized Fc Alpha receptors" was invented by John McWhirter (Hastings-On-Hudson, N.Y.), Naxin Tu (Pleasantville, N.Y.), Andrew J. Murphy (Croton-On-Hudson, N.Y.) and Lynn MacDonald (Harrison, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and compositions related to mice that express human or humanized Foot receptors (FcaR) from an FcaR locus positioned in the mouse leukocyte receptor complex (LRC). In certain embodiments, such mice are useful for in vivo testing of therapeutic agents comprising a human IgA Fc (e...